H1B Salary Data

Home › Employers › identifeye HEALTH Inc.

identifeye HEALTH Inc.: H-1B salaries and sponsorship

identifeye HEALTH Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $170,000.

Applications (LCAs)3
Certified3
Employer addressGuilford, CT
H-1B dependent employerNo
Median offered salary$170,000
Middle half of salaries$137,000–$179,524
10th–90th percentile$117,200–$185,238

Does identifeye HEALTH Inc. sponsor H-1B visas?

identifeye HEALTH Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 8, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Green card (PERM) applications at identifeye HEALTH Inc.: 3 →

Salaries by job title

Job titleLCAsMedian salary
Machine Learning II1$189,048
Machine Learning Scientist1$170,000
Mechanical Engineer1$104,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20241$189,048
FY20252$137,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Machine Learning Scientist$170,000
Level II
Redwood City, CAApr 8, 2025Oct 1, 2025Certified
Mechanical Engineer$104,000
Level III
Guilford, CTApr 2, 2025Sep 30, 2025Certified
Machine Learning II$189,048
Level II
Guilford, CTApr 25, 2024Sep 30, 2024Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).